ArticleBioengineered2021

Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis.

Runze Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.